The life sciences industry has drawn considerable interest from private equity, which injects billions of dollars into this rapidly growing segment. PE investments in life sciences peaked in 2021, when investors closed 695 PE transactions totaling $127.5 billion, according to PitchBook data. The space includes biotech and medical device companies as well as providers of related tools and services. Among the main drivers of this demand are the spectacular returns that PE investors can potentially score through life sciences deals if they bet on the right horse.
Read the full article: Meet the 5 Most Active PE Investors in Life Sciences //